Joseph Asante

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Postdoctoral Research Associate

UA Little Rock primary UAMS

3 h-index 7 pubs 28 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Joseph Asante Jnr's research investigates the intersection of drug transport mechanisms, specifically P-glycoprotein substrates, and their association with Alzheimer's disease risk. His work explores how these substrates may impact the transendothelial transport of amyloid-beta peptides, a key factor in Alzheimer's pathology. Asante Jnr has also examined the potential of ezetimibe in reducing Alzheimer's risk by inhibiting specific protein interactions involved in aggregation. His research extends to predictive modeling of viral protein mutations, with publications focusing on the structural and functional impacts of SARS-CoV-2 spike protein mutations. Collaborating with researchers at the University of Arkansas for Medical Sciences, including Steven W. Barger and Corey Nagel, Asante Jnr has contributed to studies on neurological disorders and disease mechanisms. His scholarship metrics include an h-index of 3, with 6 total publications and 26 citations.

Metrics

h-index: 3
Publications: 7
Citations: 28

Positions

Postdoctoral Research Associate 2024–present

University of Arkansas for Medical Sciences Geriatrics ORCID
Postdoctoral Research Associate publications 2024–2026

University of Arkansas at Little Rock ORCID

Selected Publications

Impact of P-glycoprotein substrates on transendothelial transport of amyloid-β peptide in an in vitro model (2026)

Neuroscience DOI OpenAlex
Correction: Structural and Functional Impacts of SARS-CoV-2 Spike Protein Mutations: Insights From Predictive Modeling and Analytics (2025)

JMIR Bioinformatics and Biotechnology DOI OpenAlex
Impact of P-Glycoprotein Substrates on Transendothelial Transport of Amyloid-β Peptide (2025)

SSRN Electronic Journal DOI OpenAlex
Structural and Functional Impacts of SARS-CoV-2 Spike Protein Mutations: Insights From Predictive Modeling and Analytics (2025)

JMIR Bioinformatics and Biotechnology 4 citations DOI OpenAlex
Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study (2025)

Journal of Alzheimer s Disease 2 citations DOI OpenAlex
P-glycoprotein and Alzheimer’s Disease: Threats and Opportunities (2025)

ASN NEURO 4 citations DOI OpenAlex
Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction (2024)

12 citations DOI OpenAlex